Jeffrey R. Stewart is Executive Vice President, Commercial
Operations. He is responsible for leading the largest commercial area
for the enterprise encompassing multiple therapeutic areas across
immunology, oncology, virology, eye care, neuroscience,
endo-metabolics, gastroenterology, specialty products and women’s health.
Mr. Stewart joined Abbott in 1992 as part of TAP, Abbott’s former
U.S. joint venture with Takeda Chemical Industries. Following his time
with TAP, Mr. Stewart held various leadership positions in Abbott’s
U.S. and international pharmaceutical businesses, including Divisional
Vice President, Immunology; Divisional Vice President, Primary Care;
General Manager, Virology; and General Manager, United Kingdom. Prior
to AbbVie's separation from Abbott in January 2013, Mr. Stewart served
as Vice President, Abbott Proprietary Pharmaceutical Division, United States.
Mr. Stewart previously led the U.S. Area for 10 years, including
most recently as Senior Vice President, U.S. Commercial
Mr. Stewart previously served on the Board of the National
Pharmaceutical Council and serves on the Board of the Pharmaceutical
Research and Manufacturers of America (PhRMA). At AbbVie, he is the
executive chair of the PRIDE Employee Resource Group.